Featuring perspectives from Dr Shilpa Gupta and Prof Thomas Powles, including the following topics: Introduction: The Cancer-Immunity Cycle (0:00) Nonmetastatic Urothelial Bladder Cancer Dr Gupta (

Featuring a slide presentation and related discussion from Dr Manish Patel, including the following topics: Pharmacology of B7-H3 and role in tumor pathogenesis (0:00) Current and future clinical dev

Featuring perspectives from Dr Manish Patel, including the following topics: Insights into a comprehensive clinical research practice (0:00) Transformation of the conduct and design of clinical trial

Featuring perspectives from Dr Robin (Katie) Kelley and Dr Mark Yarchoan, including the following topics: Introduction: Interdisciplinary Management of Hepatocellular Carcinoma (HCC) in the Communit

Featuring perspectives from Dr Melissa Johnson, including the following topics: Role of biomarker testing in optimal selection of first-line therapy for patients with non-small cell lung cancer (NSCL

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer | Faculty Presentation 2: Triple-Negative Breast C

Featuring perspectives from Dr Ian E Krop and Dr Priyanka Sharma, including the following topics: Introduction: Educating Non-Breast Cancer Specialty Oncologists About HER2-Targeted Therapies ASCO

Featuring perspectives from Dr Stephen T Oh, including the following topics: Introduction: ASH 2023 Update (0:00) Case: A woman in her early 70s with symptomatic primary myelofibrosis (MF) receives

Featuring perspectives from Dr Yelena Y Janjigian and Dr Zev Wainberg, including the following topics: Introduction: First-Line Therapy for Metastatic Gastroesophageal (GE) Cancers the Bottom Line

Featuring perspectives from Dr Ahmed Omar Kaseb and Prof Arndt Vogel, including the following topics: Introduction: EMERALD-1 Immune Checkpoint Inhibitor-Based Therapy for Localized HCC Eligible fo